Shaaltiel Yoseph

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$97,793.00
Insider Sells Quantity
16
Insider Sells Sum
$7.23M

Insider Activity of Shaaltiel Yoseph

The largest purchase of all time was on 2007-12-05 and amounted to 15100 shares of Protalix BioTherapeutics, Inc. for $47,388.

The largest sale of all time was on 2012-05-02 and amounted to 300000 shares of Protalix BioTherapeutics, Inc. for $2.14M.

Biography of Shaaltiel Yoseph

No biography is available at this moment.

2012-05-02SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
300,000
0.3334%
$7.13$2.14M-20.83%
2010-08-06SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
4,619
0.0057%
$7.00$32,333+8.62%
2010-08-05SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
48,408
0.0603%
$7.00$338,856+8.79%
2010-06-21SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
52,973
0.0665%
$7.00$370,811+9.58%
2010-04-29SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
12,691
0.0157%
$7.00$88,837+8.17%
2010-04-14SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
1,309
0.0016%
$7.00$9,163+7.36%
2010-03-25SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
50,000
0.0621%
$7.00$350,000+8.32%
2010-03-24SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
202,700
0.2521%
$7.08$1.44M+7.24%
2010-03-23SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
127,300
0.1588%
$7.02$893,646+8.48%
2009-10-19SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
43,120
0.0557%
$9.43$406,622-26.21%
2009-10-16SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
25,680
0.034%
$9.39$241,135-24.1%
2009-10-15SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
31,200
0.0406%
$9.39$292,968-25.35%
2009-07-06SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
100,000
0.1363%
$5.09$509,400+42.42%
2009-05-14SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
10,000
0.0121%
$3.85$38,500+67.07%
2009-05-13SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
20,000
0.0262%
$3.51$70,200+97.44%
2009-03-13SaleProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
8,300
0.011%
$2.18$18,094+218.06%
2007-12-19PurchaseProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
4,800
0.0063%
$3.40$16,320-20.18%
2007-12-18PurchaseProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
5,100
0.0065%
$3.40$17,335-22%
2007-12-17PurchaseProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
5,000
0.0064%
$3.35$16,750-20.81%
2007-12-05PurchaseProtalix BioTherapeutics, Inc.
PLX
Executive VP, R&D
15,100
0.0177%
$3.14$47,388-22.1%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.